Point of Care Respiratory
Acceava hCG Basic II Acceava hCG Urine II Acceava hCG Combo II BioStar OIA STREP B Clearview hCG Dipstick Clearview hCG Cassette Clearview hCG Combo II Clearview 25 hCG Combo RUBELLA-plus
Acceava®, BinaxNOW®, BioStar®, Clearview®, OIA® and RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies.
Rubella-plus

Rubella-plus is an immunochromatographic assay for the qualitative detection of Rubella antibody (IgG) in human serum or plasma.

Clearly different

Rubella-plus provides simple, accurate detection of rubella antibodies.

  • Fast: results available in just 15 minutes
  • Easy: no special training or rotator needed
  • Reliable: detects antibodies at a level greater than or equal to 10 IU/mL
  • Flexible: can be used with either serum or plasma samples

 

Clearly better

The rapid, reliable results provided by Rubella-plus can lead to improved patient care. Early detection in women of child-bearing age may prevent the transmission of the disease to unborn children

Procedure

Add sample and developer.
Add 10 µL serum or plasma to sample window S.
Add 3 to 4 drops of developer solution to window D.

Read results.
Results appear in 6-15 minutes. For full instructions, see package insert.

About Rubella

Rubella (also called German measles or 3-day measles) is a disease caused by the rubella virus. Rubella spreads from person to person through the air (often through close contact such as talking, coughing, or sneezing) and is moderately contagious.

Although rubella can strike people of all ages, it poses the greatest danger to unborn babies. Congenital rubella syndrome (CRS) occurs when the rubella virus attacks a developing fetus. Up to 85% of infants infected during the first trimester will be born with birth defects, including deafness, blindness, heart defects, and mental retardation.1 Miscarriages are also common.2

Fortunately, due to widespread immunization with a rubella vaccine, rubella and CRS are now uncommon in the U.S.1 Rubella vaccine is often given together with measles and mumps vaccines as part of an MMR shot.

Reference

  1. Immunization Action Coalition. Vaccine Information for the Public and Health Professionals: Rubella Questions and Answers. Available at: http://www.vaccineinformation.org/rubella/qandadis.asp. Accessed April 21, 2005.
  2. Centers for Disease Control. Parents Guide to Childhood Immunization: Rubella (German Measles). Available at: http://www.cdc.gov/nip/publications/Parents-Guide/pg-rubella.pdf. Accessed April 21, 2005.

 

Specifications

Order No. 84R2

Qty: 30 Tests

CPT*: 86762, 86318, 87899

CLIA: Non-waived

Contact: (800) 637-3717

Rubella-plusUseful Downloads Product Brochure Package Insert
* It is always the provider's responsibility to establish appropriate coding & charges.